DEUTSCHE BANK AG\ - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 93 filers reported holding CARDIFF ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q4 2022$313,680
-9.1%
224,0570.0%0.00%
Q3 2022$345,000
-30.0%
224,0570.0%0.00%
Q2 2022$493,000
-18.8%
224,057
-8.5%
0.00%
Q1 2022$607,000
-59.2%
244,738
-1.0%
0.00%
-100.0%
Q4 2021$1,486,000
-9.3%
247,196
+0.5%
0.00%0.0%
Q3 2021$1,638,000
-23.4%
245,964
-23.5%
0.00%0.0%
Q2 2021$2,139,000
-13.0%
321,622
+21.1%
0.00%0.0%
Q1 2021$2,459,000
+739.2%
265,594
+1530.0%
0.00%
Q4 2020$293,00016,2940.00%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
CAXTON CORP 2,522,083$15,158,00012.39%
Octagon Capital Advisors LP 982,753$5,906,0001.15%
Altium Capital Management LP 337,000$2,025,0000.56%
ACT CAPITAL MANAGEMENT, LLC 102,500$616,0000.44%
Eventide Asset Management 1,670,399$10,039,0000.13%
Artal Group S.A. 750,000$4,508,0000.12%
Aquatic Capital Management LLC 8,000$48,0000.09%
ELKHORN PARTNERS LIMITED PARTNERSHIP 17,300$104,0000.06%
Anson Funds Management LP 69,381$417,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 170,447$1,024,0000.02%
View complete list of CARDIFF ONCOLOGY INC shareholders